Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald A Soff

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Contraception|June 23, 2004
Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptivesStephen Sidney, Diana B Petitti, Gerald A Soff, et al.
Clinical Imaging|June 15, 2014
Clinical consequences of an indeterminate CT pulmonary angiogram in cancer patientsSara A Hayes, Gerald A Soff, Emily C Zabor, et al.
Research and Practice in Thrombosis and Haemostasis|May 4, 2026
A comprehensive assessment of the impact of COVID variant and vaccination on venous thromboembolism and mortalitySamuel P Soff, Richard Moffitt, Anjali Sharathkumar, et al.
Investigational New Drugs|March 10, 2023
A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studiesDanny N Khalil, Isabel Prieto González-Albo, Lee Rosen, et al.
Investigational New Drugs|May 11, 2023
Correction to: A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studiesDanny N Khalil, Isabel Prieto González-Albo, Lee Rosen, et al.
Research and Practice in Thrombosis and Haemostasis|May 18, 2022
Romiplostim for chemotherapy-induced thrombocytopenia: Efficacy and safety of extended useCy R Wilkins, Jocelyn Ortiz, Leah J Gilbert, et al.
Biology of Reproduction|October 29, 2010
Thrombophilic-type placental pathologies and skeletal growth delay following maternal administration of angiostatin4.5 in miceCatrin S Rutland, Sarah D Atkinson, Mallinath Mukhopadhyay, et al.
Plos One|June 9, 2022
Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopeniaGerald A Soff, Isabelle Ray-Coquard, Luis J Marfil Rivera, et al.
Cancer Research|July 23, 2003
Angiostatin(4.5)-mediated apoptosis of vascular endothelial cellsHolly Anne Hanford, Christie A Wong, Hallie Kassan, et al.
Journal of Medicinal Chemistry|May 13, 2005
N-methylsansalvamide a peptide analogues. Potent new antitumor agentsShouxin Liu, Wenxin Gu, Denise Lo, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Contraception|June 23, 2004
Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptivesStephen Sidney, Diana B Petitti, Gerald A Soff, et al.
Clinical Imaging|June 15, 2014
Clinical consequences of an indeterminate CT pulmonary angiogram in cancer patientsSara A Hayes, Gerald A Soff, Emily C Zabor, et al.
Research and Practice in Thrombosis and Haemostasis|May 4, 2026
A comprehensive assessment of the impact of COVID variant and vaccination on venous thromboembolism and mortalitySamuel P Soff, Richard Moffitt, Anjali Sharathkumar, et al.
Investigational New Drugs|March 10, 2023
A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studiesDanny N Khalil, Isabel Prieto González-Albo, Lee Rosen, et al.
Investigational New Drugs|May 11, 2023
Correction to: A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studiesDanny N Khalil, Isabel Prieto González-Albo, Lee Rosen, et al.
Research and Practice in Thrombosis and Haemostasis|May 18, 2022
Romiplostim for chemotherapy-induced thrombocytopenia: Efficacy and safety of extended useCy R Wilkins, Jocelyn Ortiz, Leah J Gilbert, et al.
Biology of Reproduction|October 29, 2010
Thrombophilic-type placental pathologies and skeletal growth delay following maternal administration of angiostatin4.5 in miceCatrin S Rutland, Sarah D Atkinson, Mallinath Mukhopadhyay, et al.
Plos One|June 9, 2022
Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopeniaGerald A Soff, Isabelle Ray-Coquard, Luis J Marfil Rivera, et al.
Cancer Research|July 23, 2003
Angiostatin(4.5)-mediated apoptosis of vascular endothelial cellsHolly Anne Hanford, Christie A Wong, Hallie Kassan, et al.
Journal of Medicinal Chemistry|May 13, 2005
N-methylsansalvamide a peptide analogues. Potent new antitumor agentsShouxin Liu, Wenxin Gu, Denise Lo, et al.
Pageof 7